Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Provectus Biopharmaceuticals Inc (QB) | PVCT | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0528 | 0.0528 | 0.05525 | 0.05525 | 0.055 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
6/23/2022 | 09:14 | EDGAR | Current Report Filing (8-k) |
6/22/2022 | 09:04 | EDGAR | Additional Proxy Soliciting Materials (definitive) (defa14a) |
6/22/2022 | 09:01 | EDGAR | Current Report Filing (8-k) |
5/26/2022 | 13:28 | EDGAR | Additional Proxy Soliciting Materials (definitive) (defa14a) |
5/12/2022 | 13:49 | EDGAR | Quarterly Report (10-q) |
4/29/2022 | 08:32 | EDGAR | Additional Proxy Soliciting Materials (definitive) (defa14a) |
4/29/2022 | 08:22 | EDGAR | Proxy Statement (definitive) (def 14a) |
4/19/2022 | 16:32 | EDGAR | Current Report Filing (8-k) |
4/19/2022 | 15:37 | EDGAR | Proxy Statement - Notice of Shareholders Meeting.. |
3/29/2022 | 16:05 | EDGAR | Annual Report (10-k) |
3/24/2022 | 08:06 | SEEK | Provectus reports synthesis of new halogenated xanthene.. |
9/07/2021 | 15:34 | EDGAR | Current Report Filing (8-k) |
8/30/2021 | 16:03 | EDGAR | Small Company Offering and Sale of Securities Without.. |
8/18/2021 | 08:28 | EDGAR | Current Report Filing (8-k) |